| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |